Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Biotech
Alltrna CEO departs amid 35% layoff round
Flagship Pioneering-backed Alltrna is once again laying off staff, this time reducing its workforce by 19 people.
Gabrielle Masson
Mar 6, 2026 8:30pm
CBER Director Vinay Prasad to depart FDA—again
Mar 6, 2026 5:30pm
How physiology powers biotech innovation
Brought to you by
American Physiological Society
Fierce Biotech Layoff Tracker 2026: Vertex, Alltrna & more
Mar 6, 2026 4:00pm
Carl Sailer on AI, market trends, and strategic planning in biotech
Brought to you by
Syneos Health
FDA to end 9-month adcomm hiatus with review of AZ's cancer drugs
Mar 6, 2026 11:16am